Ozlem Ozer Cakir1, Hasan Esen2, Aysun Toker3, Huseyin Ataseven4, Ali Demir4, Hakki Polat4. 1. Department of Gastroenterology and Hepatology, Konya Education and Research Hospital Konya, Turkey. 2. Department of Pathology, Meram School of Medicine, Necmettin Erbakan University Konya, Turkey. 3. Department of Biochemistry, Meram School of Medicine, Necmettin Erbakan University Konya, Turkey. 4. Department of Gastroenterology and Hepatology, Meram School of Medicine, Necmettin Erbakan University Konya, Turkey.
Abstract
BACKGROUND: Research continues to develop novel therapeutic modalities that particularly focus on the pathogenesis of acute pancreatitis. This study aimed to assess the effects of diclofenac sodium and octreotide, alone or in combination, on pancreatic enzymes, pancreatic myeloperoxidase activity, histopathology and apoptosis of pancreas cells, using a model of experimentally induced acute pancreatitis. OBJECTIVES: We aimed to demonstrate effects of diclofenac sodium, octreotide and their combined use on pancreatic enzymes, activity of pancreatic myeloperoxidase (MPO) activity, histopathology and apoptosis of pancreas on treatment of caerulin-induced experimental acute pancreatitis. MATERIALS AND METHODS: Caerulin-induced acute pancreatitis model was created using a total of 58 male BALB-C mice of 25 gr in seven groups. Serum amylase, lipase levels and pancreatic myeloperoxidase activity were examined as well as apoptotic values in pancreatic acinar cells through TUNNEL method. Histopathology of pancreas was evaluated for presence of edema, hemorrhage, parenchymal necrosis, fat necrosis, leukocyte infiltration, and fibrosis. RESULTS: In the diclofenac sodium group, apoptotic values in the pancreatic acinar cells were found to be statistically lower than in the acute pancreatitis group in terms of parenchymal necrosis and hemorrhage scores (P = 0.007, P = 0.002, and P = 0.052, respectively). No statistically significant differences were found in serum level of amylase, lipase, pancreatic myeloperoxidase activity and the other histopathological scores (P > 0.05). CONCLUSION: Diclofenac sodium, a cost-effective agent with a favorable side-effect profile, may represent a novel therapeutic agent for the treatment of acute pancreatitis. Findings of this study suggest a better efficacy for diclofenac sodium monotherapy as compared to octreotide alone or octreotide/diclofenac combination.
BACKGROUND: Research continues to develop novel therapeutic modalities that particularly focus on the pathogenesis of acute pancreatitis. This study aimed to assess the effects of diclofenac sodium and octreotide, alone or in combination, on pancreatic enzymes, pancreaticmyeloperoxidase activity, histopathology and apoptosis of pancreas cells, using a model of experimentally induced acute pancreatitis. OBJECTIVES: We aimed to demonstrate effects of diclofenac sodium, octreotide and their combined use on pancreatic enzymes, activity of pancreaticmyeloperoxidase (MPO) activity, histopathology and apoptosis of pancreas on treatment of caerulin-induced experimental acute pancreatitis. MATERIALS AND METHODS: Caerulin-induced acute pancreatitis model was created using a total of 58 male BALB-C mice of 25 gr in seven groups. Serum amylase, lipase levels and pancreaticmyeloperoxidase activity were examined as well as apoptotic values in pancreatic acinar cells through TUNNEL method. Histopathology of pancreas was evaluated for presence of edema, hemorrhage, parenchymal necrosis, fat necrosis, leukocyte infiltration, and fibrosis. RESULTS: In the diclofenac sodium group, apoptotic values in the pancreatic acinar cells were found to be statistically lower than in the acute pancreatitis group in terms of parenchymal necrosis and hemorrhage scores (P = 0.007, P = 0.002, and P = 0.052, respectively). No statistically significant differences were found in serum level of amylase, lipase, pancreaticmyeloperoxidase activity and the other histopathological scores (P > 0.05). CONCLUSION:Diclofenac sodium, a cost-effective agent with a favorable side-effect profile, may represent a novel therapeutic agent for the treatment of acute pancreatitis. Findings of this study suggest a better efficacy for diclofenac sodium monotherapy as compared to octreotide alone or octreotide/diclofenac combination.
Authors: A Andriulli; G Leandro; R Clemente; V Festa; N Caruso; V Annese; G Lezzi; E Lichino; F Bruno; F Perri Journal: Aliment Pharmacol Ther Date: 1998-03 Impact factor: 8.171
Authors: B Poch; F Gansauge; B Rau; U Wittel; S Gansauge; A K Nüssler; M Schoenberg; H G Beger Journal: FEBS Lett Date: 1999-11-19 Impact factor: 4.124
Authors: J Sánchez Manuel; J I Landa García; J L Seco Gil; A Velasco Oses; M J Coma del Corral; C Vaquero Puerta; J L Santamaría García Journal: Rev Esp Enferm Dig Date: 1997-02 Impact factor: 2.086
Authors: Marcelo Z Salem; J Eduardo M Cunha; Ana M Coelho; Sandra N Sampietri; Marcel C C Machado; Sonia Penteado; Emílio E Abdo Journal: Pancreatology Date: 2003 Impact factor: 3.996
Authors: Jorge D Machicado; Rawad Mounzer; Pedram Paragomi; Ioannis Pothoulakis; Phil A Hart; Darwin L Conwell; Enrique de-Madaria; Phil Greer; Dhiraj Yadav; David C Whitcomb; Peter J Lee; Alice Hinton; Georgios I Papachristou Journal: Clin Transl Gastroenterol Date: 2021-10-27 Impact factor: 4.488